NCT07388771Recruiting
Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
A Study on Multimodal Data Prediction of Outcome to Neoadjuvant Therapy in NSCLC
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC. The core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 28 Jan 2026
- Start date
- 1 Dec 2025
- Primary completion date
- 31 Oct 2026
- Lead sponsor
- Qian Chu
- Diseases
- Lung cancer
- NCT number
- NCT07388771
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Dec 2025 to the primary completion date, 31 Oct 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- recurrent or metastatic lung cancer;
Other
- patients with other primary tumors
Who the study is looking for
- pathologically diagnosed non-small cell lung cancer
- The treatment plan is：receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sir Run Run Shaw Hospital Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
| Tongji Hospital Coordinator of this site? Confirm its status | Wuhan | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.